Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antineoplastic agent |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01AD01
|
| gptkbp:CASNumber |
154-93-8
|
| gptkbp:developedBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:genericName |
gptkb:carmustine
|
| gptkbp:hasMolecularFormula |
C5H9Cl2N3O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
BiCNU
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:sideEffect |
nausea
vomiting pulmonary toxicity bone marrow suppression |
| gptkbp:synonym |
gptkb:BCNU
|
| gptkbp:usedFor |
treatment of Hodgkin's lymphoma
treatment of brain tumors treatment of multiple myeloma treatment of non-Hodgkin's lymphoma |
| gptkbp:bfsParent |
gptkb:carmustine
|
| gptkbp:bfsLayer |
7
|